Table of Contents

Molecular Oncology, Markers, Clinical Correlates

• Molecular Oncology, Markers, Clinical Correlates

  Overexpression of Cyclooxygenase-2 in Carcinoma of the Pancreas

  Jiro Okami, Hirofumi Yamamoto, Yoshiyuki Fujiwara, Masaki Tsujie, Motoi Kondo, Shingo Noura, Satoshi Oshima, Hiroaki Nagano, Keizo Dono, Koji Umeshita, Osamu Ishikawa, Masato Sakon, Nariaki Matsuura, Shoji Nakamori and Morito Monden

  Clin Cancer Res August 1 1999 5 (8) 2018-2024;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Loss of Heterozygosity in Epithelial Cells Obtained by Bronchial Brushing: Clinical Utility in Lung Cancer

  Charles A. Powell, Scott Klares, George O’Connor and Jerome S. Brody

  Clin Cancer Res August 1 1999 5 (8) 2025-2034;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Prognostic Value of Ornithine Decarboxylase and Polyamines in Human Breast Cancer: Correlation with Clinicopathologic Parameters

  Francisco Cañizares, Juan Salinas, Manuel de las Heras, Julian Diaz, Isabel Tovar, Pedro Martinez and Rafael Peñafiel

  Clin Cancer Res August 1 1999 5 (8) 2035-2041;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Association between Molecular Detection of GAGE and Survival in Patients with Malignant Melanoma: A Retrospective Cohort Study

  Irene Y. Cheung, Nai-Kong V. Cheung, Ronald A. Ghossein, Jaya M. Satagopan, Satyajit Bhattacharya and Daniel G. Coit

  Clin Cancer Res August 1 1999 5 (8) 2042-2047;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Expression of DNA Topoisomerase IIα and Topoisomerase IIβ Genes Predicts Survival and Response to Chemotherapy in Patients with Small Cell Lung Cancer

  Anne-Marie C. Dingemans, M. Adhiambo Witlox, Roland A. L. M. Stallaert, Paul van der Valk, Pieter E. Postmus and Giuseppe Giaccone

  Clin Cancer Res August 1 1999 5 (8) 2048-2058;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  O⁶-Alkylguanine-DNA Alkyltransferase in Cutaneous T-Cell Lymphoma: Implications for Treatment with Alkylating Agents

  M. Eileen Dolan, Bradford L. McRae, Elizabeth Ferries-Rowe, Michael Belanich, Gijs A. van Seventer, Joan Guitart, David Pezen, Timothy M. Kuzel and Daniel B. Yarosh

  Clin Cancer Res August 1 1999 5 (8) 2059-2064;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Prognostic Significance of Perirectal Lymph Node Micrometastases in Dukes’ B Rectal Carcinoma: An Immunohistochemical Study by CAM5.2

  Naohide Isaka, Mutsumi Nozue, Mikio Doy and Katashi Fukao

  Clin Cancer Res August 1 1999 5 (8) 2065-2068;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Overexpression of Cyclin D1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer

  Frances S. Kenny, Rina Hui, Elizabeth A. Musgrove, Julia M.W. Gee, Roger W. Blamey, Robert I. Nicholson, Robert L. Sutherland and John F. R. Robertson

  Clin Cancer Res August 1 1999 5 (8) 2069-2076;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer

  Antonio Marchetti, Gloria Bertacca, Fiamma Buttitta, Antonio Chella, Gianluca Quattrocolo, Carlo Alberto Angeletti and Generoso Bevilacqua

  Clin Cancer Res August 1 1999 5 (8) 2077-2081;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Inactivation of the p53 Pathway in Prostate Cancer: Impact on Tumor Progression

  Iman Osman, Marija Drobnjak, Melissa Fazzari, Joseph Ferrara, Howard I. Scher and Carlos Cordon-Cardo

  Clin Cancer Res August 1 1999 5 (8) 2082-2088;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Wild-Type p53 Epitope Naturally Processed and Presented by an HLA-B Haplotype on Human Breast Carcinoma Cells

  Kyriakos P. Papadopoulos, Charles S. Hesdorffer, Nicole Suciu-Foca, Hanina Hibshoosh and Paul E. Harris

  Clin Cancer Res August 1 1999 5 (8) 2089-2093;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Expression of Plasminogen Activator Inhibitors 1 and 2 in Lung Cancer and Their Role in Tumor Progression

  Catherine Robert, Isabelle Bolon, Sylvie Gazzeri, Sylvie Veyrenc, Christian Brambilla and Elisabeth Brambilla

  Clin Cancer Res August 1 1999 5 (8) 2094-2102;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  The Human Orphan Receptor PXR Messenger RNA Is Expressed in Both Normal and Neoplastic Breast Tissue

  Helmut Dotzlaw, Etienne Leygue, Peter Watson and Leigh C. Murphy

  Clin Cancer Res August 1 1999 5 (8) 2103-2107;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Sequences Homologous to the Mouse Mammary Tumor Virus env Gene in Human Breast Carcinoma Correlate with Overexpression of Laminin Receptor

  Beatriz G-T. Pogo, Stella M. Melana, James F. Holland, John F. Mandeli, Silvana Pilotti, Patrizia Casalini and Sylvie Ménard

  Clin Cancer Res August 1 1999 5 (8) 2108-2111;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Expression of Dominant-Negative Ikaros Isoforms in T-Cell Acute Lymphoblastic Leukemia

  Lei Sun, Mya-Lisa Crotty, Martha Sensel, Harland Sather, Christopher Navara, James Nachman, Peter G. Steinherz, Paul S. Gaynon, Nita Seibel, Chen Mao, Alexei Vassilev, Gregory H. Reaman and Fatih M. Uckun

  Clin Cancer Res August 1 1999 5 (8) 2112-2120;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Minichromosome Maintenance Proteins as Biological Markers of Dysplasia and Malignancy

  Alex Freeman, Lesley S. Morris, Anthony D. Mills, Kai Stoeber, Ronald A. Laskey, Gareth H. Williams and Nicholas Coleman

  Clin Cancer Res August 1 1999 5 (8) 2121-2132;

  
  
• Molecular Oncology, Markers, Clinical Correlates

  Analysis of Cyclin D1 (CCND1) Allelic Imbalance and Overexpression in Sporadic Human Pituitary Tumors

  Nigel A. Hibberts, David J. Simpson, John E. Bicknell, John C. Broome, Paul R. Hoban, Richard N. Clayton and William E. Farrell

  Clin Cancer Res August 1 1999 5 (8) 2133-2139;